TCRT
Alaunos Therapeutics Inc
NASDAQ: TCRT · HEALTHCARE · BIOTECHNOLOGY
$2.55
-0.39% today
Updated 2026-04-30
Market cap
$6.16M
P/E ratio
—
P/S ratio
1,231.94x
EPS (TTM)
$-2.20
Dividend yield
—
52W range
$2 – $5
Volume
0.0M
Alaunos Therapeutics Inc (TCRT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $667000.00 | $800000.00 | $800000.00 | $1.37M | $4.33M | $6.86M | $6.39M | $146000.00 | $0.00 | $0.00 | $398000.00 | $2.92M | $5000.00 | $10000.00 | $5000.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | +19.9% | +0.0% | +71.6% | +215.5% | +58.4% | -6.9% | -97.7% | -100.0% | — | — | +634.2% | -99.8% | +100.0% | -50.0% |
| Cost of revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | $629000.00 | $1.13M | $740000.00 | $2.76M | $4.80M | — | — |
| Gross profit | — | — | — | — | — | $667000.00 | $800000.00 | $800000.00 | $1.37M | $4.33M | $6.86M | $6.39M | $146000.00 | $-629000.00 | $-1.13M | $398000.00 | $2.92M | $-4.80M | $10000.00 | $5000.00 |
| Gross margin | — | — | — | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — | 100.0% | 100.0% | -95960.0% | 100.0% | 100.0% |
| R&D | $10.39M | $18.99M | $17.25M | $4.56M | $12.91M | $57.08M | $83.45M | $42.85M | $32.71M | $106.78M | $157.79M | $45.08M | $34.13M | $38.33M | $52.70M | $49.64M | $25.02M | $16.28M | $362000.00 | $1.36M |
| SG&A | $8.72M | $773141.00 | $8.37M | $7.57M | $11.64M | $14.98M | $19.52M | $15.66M | $12.17M | $17.65M | $14.38M | $14.80M | $19.92M | $19.53M | $27.66M | $27.56M | $13.14M | $12.22M | $4.46M | $2.87M |
| Operating income | $-19.11M | $-28.57M | $-25.62M | $-12.12M | $-24.55M | $-71.40M | $-102.17M | $-57.71M | $-43.50M | $-120.10M | $-165.31M | $-53.49M | $-53.91M | $-57.86M | $-80.36M | $-77.55M | $-35.10M | $-34.27M | $-4.81M | $-4.22M |
| Operating margin | — | — | — | — | — | -10704.6% | -12771.1% | -7214.1% | -3168.2% | -2772.4% | -2409.4% | -837.3% | -36921.9% | — | — | -19484.7% | -1201.4% | -685340.0% | -48120.0% | -84500.0% |
| EBITDA | $-17.68M | $-26.17M | $-24.84M | $-7.32M | $-32.48M | $-71.40M | $-102.17M | $-56.98M | $-43.50M | $-119.74M | $-165.01M | $-53.12M | $-53.33M | $-117.17M | $-79.23M | $-74.97M | $-31.82M | $-30.90M | $-4.68M | $-4.22M |
| EBITDA margin | — | — | — | — | — | -10704.6% | -12771.1% | -7121.9% | -3168.2% | -2764.2% | -2405.0% | -831.5% | -36528.1% | — | — | -18835.4% | -1088.9% | -618080.0% | -46770.0% | -84500.0% |
| EBIT | $-17.86M | $-26.61M | $-25.23M | $-7.65M | $-32.67M | $-71.67M | $-102.83M | $-57.71M | $-43.96M | $-120.10M | $-165.30M | $-53.49M | $-53.90M | $-117.80M | $-80.36M | $-77.56M | $-34.58M | $-33.22M | $-4.68M | $-4.23M |
| Interest expense | — | — | — | $4.47M | $8.12M | $7.62M | $6.04M | $606000.00 | $11.72M | $12000.00 | $10000.00 | $830000.00 | $789000.00 | $120.69M | $385000.00 | $1.19M | $3.15M | $1.92M | $0.00 | — |
| Income tax | $-1.25M | $-1.96M | $-388000.00 | $-8.95M | $16.25M | $-15.24M | $-12.09M | $-1.79M | $-23.44M | $-12000.00 | $114000.00 | $2.13M | $-947000.00 | $60.12M | $-1.13M | $-1.86M | $-133000.00 | $2.15M | — | — |
| Effective tax rate | 6.6% | 6.9% | 1.5% | 53.9% | -98.9% | 19.3% | 11.2% | 3.0% | 42.4% | 0.0% | -0.1% | -4.1% | 1.8% | -104.2% | 1.4% | 2.3% | 0.4% | -6.5% | 0.0% | 0.0% |
| Net income | $-17.86M | $-26.61M | $-25.23M | $-7.65M | $-32.67M | $-63.78M | $-96.13M | $-57.11M | $-31.78M | $-120.09M | $-165.30M | $-54.32M | $-53.12M | $-117.80M | $-78.85M | $-78.75M | $-37.73M | $-35.14M | $-4.68M | $-4.18M |
| Net income growth (YoY) | — | -49.0% | +5.2% | +69.7% | -327.1% | -95.2% | -50.7% | +40.6% | +44.3% | -277.9% | -37.6% | +67.1% | +2.2% | -121.8% | +33.1% | +0.1% | +52.1% | +6.9% | +86.7% | +10.8% |
| Profit margin | — | — | — | — | — | -9561.9% | -12016.5% | -7138.4% | -2314.7% | -2772.1% | -2409.2% | -850.3% | -36381.5% | — | — | -19786.7% | -1291.2% | -702800.0% | -46790.0% | -83520.0% |